Tag: Clinical Study

Amgen and Allergan Announced Positive Results from Clinical Study of Rituxan®

research
Amgen and Allergan plc. announced positive top-line results from a comparative clinical study evaluating the efficacy and safety of ABP 798, a biosimilar candidate to Rituxan® (rituximab), compared to...

Janssen Announced Positive Top-Line Results from Study of Cabotegravir

hiv
The Janssen Pharmaceutical Companies of Johnson & Johnson have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen o...

ViiV Healthcare Announced Positive Results from Clinical Study of Combo for HIV Treatment

viiv healthcare
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced positive headline results from its global phase III ATLAS-2M ...

Eli Lilly Announced Superiority of Taltz® (ixekizumab) versus TREMFYA® after Phase 4 IXORA-R Study

clinical trials
Eli Lilly and Company announced Taltz® (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety of Taltz versu...

Digital Devices May Help Identify Mild Alzheimer’s Disease Dementia, Lilly Study Showed

lilly
Initial results from a feasibility study conducted by Eli Lilly and Company, Evidation Health, and Apple Inc. showed that an iPhone, Apple Watch, iPad and the Beddit sleep monitoring device, in combin...

Boehringer Ingelheim Updated Real-World Data on Gilotrif

Boehringer Ingelheim announced updated, interim analysis results from the GioTag study, showing that initiating treatment with afatinib followed by osimertinib provided an overall survival (OS) of alm...

Pfizer Announced Negative Phase 3 Results for Rivipansel

pfizer
Pfizer announced that the Phase 3 Rivipansel (GMI1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did not meet its primary or key secondary efficacy endpoints. The obj...

Study of Roche’s Tecentriq plus Platinum-Based Chemotherapy Met its Endpoint

roche
Roche announced that the Phase III IMvigor130 study met its co-primary endpoint of investigator-assessed progression-free survival. The combination of Tecentriq® (atezolizumab) plus platinum-based ...

Daiichi Sankyo Published Results of the Phase 3 Study of the Bempedoic Acid/Ezetimibe Combo

Daiichi Sankyo Europe GMbH announced that results from the 12-week, pivotal Phase 3 bempedoic acid / ezetimibe FDC tablet study (also known as Study 053) were published in the European Journal of Prev...

PureTech Health Acquired New Clinical-Stage Program LYT-100

deal
PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, announced it has acquired and plans to develop a clinical-sta...

GSK Announced Positive Results of ZEJULA Phase 3 Study

GlaxoSmithKline plc announced positive results from PRIMA, the Phase 3 randomized, double-blind, placebo-controlled, study of ZEJULA (niraparib) as a maintenance therapy in patients with first-line ov...

Johnson & Johnson Announced Results from the Phase 3 Study of XARELTO®

johnson&johnson
The Janssen Pharmaceutical Companies of Johnson & Johnson announced new results from the Phase 3 EINSTEIN-Jr study, showing pediatric patients (aged birth to 17 years) treated with XARELTO® (rivar...

Samsung Bioepis Announced Findings of 3-Year Study

Samsung Bioepis Co., Ltd. announced findings of a three-year follow-up study comparing biosimilar ONTRUZANT® (trastuzumab) and reference medicine trastuzumab in early or locally advanced HER2-positive...

BioArctic Started Clinical Study for Parkinon’s Treatment

BioArctic AB announced that the first clinical study with ABBV-0805 has started in the U.S. AbbVie is responsible for the clinical development of ABBV-0805. The Phase 1 study in healthy volunteers wil...

Bayer Clinical Study of Tropical Disease Treatment Met Endpoint

Largest clinical treatment study to date in pediatric patients with Chagas disease. Bayer today presented the results of the CHICO (CHagas disease In Children treated with NifurtimOx) phase III cli...

Celgene Cancer Treatment Therapy Not Reach Endpoint

Top-line results announced from the international Phase 3 study evaluating adjuvant therapy with ABRAXANE in combination with gemcitabine vs. gemcitabine alone for patients with surgically resected pa...